Paper42388231
Biodegradable lipid nanoparticles for genome editing in the brain via intrathecal administration.
Dong S and 14 others. Mater Today (Kidlington), 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Biodegradable lipid nanoparticles for genome editing in the brain via intrathecal administration. Papers, record 42388231. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42388231
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Biodegradable lipid nanoparticles for genome editing in the brain via intrathecal administration.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 HL174773 | NHLBI NIH HHS | United States | R01HL174773 | PubMed |
Source NIH RePORTER
References59
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21825241 | The dynamics of cortical and hippocampal atrophy in Alzheimer disease. | Arch Neurol | 2011 | https://conductscience.org/library/papers/21825241 | PubMed |
| 2 | 40147373 | Facile lipid nanoparticle size engineering approach via controllable fusion induced by depletion forces. | J Colloid Interface Sci | 2025 | https://conductscience.org/library/papers/40147373 | PubMed |
| 3 | 35787388 | The role of lipid components in lipid nanoparticles for vaccines and gene therapy. | Adv Drug Deliv Rev | 2022 | https://conductscience.org/library/papers/35787388 | PubMed |
| 4 | 30611663 | mRNA-Based Protein Replacement Therapy for the Heart. | Mol Ther | 2019 | https://conductscience.org/library/papers/30611663 | PubMed |
| 5 | 38060560 | Combinatorial design of ionizable lipid nanoparticles for muscle-selective mRNA delivery with minimized off-target effects. | Proc Natl Acad Sci U S A | 2023 | https://conductscience.org/library/papers/38060560 | PubMed |
| 6 | 32557988 | Structural and Functional Thalamic Changes in Parkinson's Disease With Mild Cognitive Impairment. | J Magn Reson Imaging | 2020 | https://conductscience.org/library/papers/32557988 | PubMed |
| 7 | 31093018 | Nusinersen: A Novel Antisense Oligonucleotide for the Treatment of Spinal Muscular Atrophy. | J Pediatr Pharmacol Ther | 2019 | https://conductscience.org/library/papers/31093018 | PubMed |
| 8 | 35064573 | Translational Approaches for Brain Delivery of Biologics via Cerebrospinal Fluid. | Clin Pharmacol Ther | 2022 | https://conductscience.org/library/papers/35064573 | PubMed |
| 9 | 39962245 | Blood-brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system. | Nat Mater | 2025 | https://conductscience.org/library/papers/39962245 | PubMed |
| 10 | 38004577 | Non-Invasive Drug Delivery across the Blood-Brain Barrier: A Prospective Analysis. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/38004577 | PubMed |
| 11 | 27208862 | Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases. | J Control Release | 2016 | https://conductscience.org/library/papers/27208862 | PubMed |
| 12 | 40317512 | Lipid Nanoparticles Enhance mRNA Delivery to the Central Nervous System Upon Intrathecal Injection. | Adv Mater | 2025 | https://conductscience.org/library/papers/40317512 | PubMed |
| 13 | 38898231 | Gene therapy for CNS disorders: modalities, delivery and translational challenges. | Nat Rev Neurosci | 2024 | https://conductscience.org/library/papers/38898231 | PubMed |
| 14 | 28202722 | Systemic delivery of factor IX messenger RNA for protein replacement therapy. | Proc Natl Acad Sci U S A | 2017 | https://conductscience.org/library/papers/28202722 | PubMed |
| 15 | 31467368 | Fate of nanoparticles in the central nervous system after intrathecal injection in healthy mice. | Sci Rep | 2019 | https://conductscience.org/library/papers/31467368 | PubMed |
| 16 | 40653413 | RNA immunotherapy: revolutionizing cancer and autoimmune disease treatments. | Trends Mol Med | 2026 | https://conductscience.org/library/papers/40653413 | PubMed |
| 17 | 27096365 | Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. | Nature | 2016 | https://conductscience.org/library/papers/27096365 | PubMed |
| 18 | 37304036 | Advanced genetic therapies for the treatment of Rett syndrome: state of the art and future perspectives. | Front Neurosci | 2023 | https://conductscience.org/library/papers/37304036 | PubMed |
| 19 | 39030617 | Cellular and molecular mechanisms of the blood-brain barrier dysfunction in neurodegenerative diseases. | Fluids Barriers CNS | 2024 | https://conductscience.org/library/papers/39030617 | PubMed |
| 20 | 39362024 | Synthetic nanomaterials for spleen-specific mRNA delivery. | Biomaterials | 2025 | https://conductscience.org/library/papers/39362024 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42851665 | Mechanisms and determinants of mRNALipid Nanoparticle biodistribution: From pharmacokinetics to clinical translation. | Bioeng Transl Med | 2026 | https://conductscience.org/library/papers/42851665 | PubMed |
| 42198337 | Delivery of mRNA Therapeutics Beyond Infectious Diseases: Design Innovations and Applications in Oncology, Cardiovascular, and Rare Genetic Diseases. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42198337 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42388231
GET https://conductscience.org/api/papers/v1/42388231/references?page=2